Learn More
Description
Specifications
Specifications
| Antigen | p14ARF/CDKN2A |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 2.5 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 2 ug/ml |
| Formulation | Tris-Glycine and 0.15M NaCl with 0.05% Sodium Azide |
| Gene Accession No. | Q8N726 |
| Gene Alias | ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, P16, p16-INK4, p16-INK4a, P16INK4A, P19, p19Arf, TP16 |
| Gene Symbols | CDKN2A |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
